|
1
|
El-Serag HB: Hepatocellular carcinoma. N
Engl J Med. 365:1118–1127. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Armengol C, Bartolí R, Sanjurjo L, Serra
I, Amézaga N, Sala M and Sarrias MR: Role of scavenger receptors in
the pathophysiology of chronic liver diseases. Crit Rev Immunol.
33:57–96. 2013.PubMed/NCBI
|
|
3
|
Petta S and Craxi A: Hepatocellular
carcinoma and non-alcoholic fatty liver disease: From a clinical to
a molecular association. Curr Pharm Des. 16:741–752. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Song BC, Chung YH, Kim JA, Choi WB, Suh
DD, Pyo SI, Shin JW, Lee HC, Lee YS and Suh DJ: Transforming growth
factor-beta1 as a useful serologic marker of small hepatocellular
carcinoma. Cancer. 94:175–180. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Reichl P, Haider C, Grubinger M and
Mikulits W: TGF-β in epithelial to mesenchymal transition and
metastasis of liver carcinoma. Curr Pharm Des. 18:4135–4147. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Saito T, Yoshida K, Matsumoto K, Saeki K,
Tanaka Y, Ong SM, Sasaki N, Nishimura R and Nakagawa T:
Inflammatory cytokines induce a reduction in E-cadherin expression
and morphological changes in MDCK cells. Res Vet Sci. 96:288–291.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Selesniemi K, Reedy M, Gultice A, Guilbert
LJ and Brown TL: Transforming growth factor-beta induces
differentiation of the labyrinthine trophoblast stem cell line
SM10. Stem Cells Dev. 14:697–711. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kim JB, Ann YH, Park SY, Jee HG, Kim HR,
Lee JH, Yu SJ, Lee HS and Kim YJ: Side population in LX2 cells
decreased by transforming growth factor-β. Hepatol Res. 44:229–237.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Giannelli G, Mazzocca A, Fransvea E, Lahn
M and Antonaci S: Inhibiting TGF-β signaling in hepatocellular
carcinoma. Biochim Biophys Acta. 1815:214–223. 2011.PubMed/NCBI
|
|
10
|
Meindl-Beinker NM, Matsuzaki K and Dooley
S: TGF-β signaling in onset and progression of hepatocellular
carcinoma. Dig Dis. 30:514–523. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zhang Z, Zhu F, Xiao L, Wang M, Tian R,
Shi C and Qin R: Side population cells in human gallbladder cancer
cell line GBC-SD regulated by TGF-β-induced epithelial-mesenchymal
transition. J Huazhong Univ Sci Technolog Med Sci. 31:749–755.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Bonnet D and Dick JE: Human acute myeloid
leukemia is organized as a hierarchy that originates from a
primitive hematopoietic cell. Nat Med. 3:730–737. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Reya T, Morrison SJ, Clarke MF and
Weissman IL: Stem cells, cancer, and cancer stem cells. Nature.
414:105–111. 2001. View
Article : Google Scholar : PubMed/NCBI
|
|
14
|
Cioce M, Gherardi S, Viglietto G, Strano
S, Blandino G, Muti P and Ciliberto G: Mammosphere-forming cells
from breast cancer cell lines as a tool for the identification of
CSC-like- and early progenitor-targeting drugs. Cell Cycle.
9:2878–2887. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Pinto CA, Widodo E, Waltham M and Thompson
EW: Breast cancer stem cells and epithelial mesenchymal
plasticity-implications for chemoresistance. Cancer Lett.
341:56–62. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kai K, Arima Y, Kamiya T and Saya H:
Breast cancer stem cells. Breast Cancer. 17:80–85. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Michishita M, Ezaki S, Ogihara K, Naya Y,
Azakami D, Nakagawa T, Sasaki N, Arai T, Shida T and Takahashi K:
Identification of tumor-initiating cells in a canine hepatocellular
carcinoma cell line. Res Vet Sci. 96:315–322. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Chiba T, Kita K, Zheng YW, Yokosuka O,
Saisho H, Iwama A, Nakauchi H and Taniguchi H: Side population
purified from hepatocellular carcinoma cells harbors cancer stem
cell-like properties. Hepatology. 44:240–251. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Dietrich CG, Geier A, Wasmuth HE, Matern
S, Gartung C, de Waart DR and Elferink RP: Influence of biliary
cirrhosis on the detoxification and elimination of a food derived
carcinogen. Gut. 53:1850–1855. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Goodell MA, Brose K, Paradis G, Conner AS
and Mulligan RC: Isolation and functional properties of murine
hematopoietic stem cells that are replicating in vivo. J Exp Med.
183:1797–1806. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Damdinsuren B, Nagano H, Kondo M, Natsag
J, Hanada H, Nakamura M, Wada H, Kato H, Marubashi S, Miyamoto A,
et al: TGF-beta1-induced cell growth arrest and partial
differentiation is related to the suppression of Id1 in human
hepatoma cells. Oncol Rep. 15:401–408. 2006.PubMed/NCBI
|
|
22
|
Baek HJ, Pishvaian MJ, Tang Y, Kim TH,
Yang S, Zouhairi ME, Mendelson J, Shetty K, Kallakury B, Berry DL,
et al: Transforming growth factor-β adaptor, β2-spectrin, modulates
cyclin dependent kinase 4 to reduce development of hepatocellular
cancer. Hepatology. 53:1676–1684. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Senturk S, Mumcuoglu M, Gursoy-Yuzugullu
O, Cingoz B, Akcali KC and Ozturk M: Transforming growth
factor-beta induces senescence in hepatocellular carcinoma cells
and inhibits tumor growth. Hepatology. 52:966–974. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Hashimoto O, Ueno T, Kimura R, Ohtsubo M,
Nakamura T, Koga H, Torimura T, Uchida S, Yamashita K and Sata M:
Inhibition of proteasome-dependent degradation of Wee1 in
G2-arrested Hep3B cells by TGF beta 1. Mol Carcinog. 36:171–182.
2003. View
Article : Google Scholar : PubMed/NCBI
|
|
25
|
Hu X, Rui W, Wu C, He S, Jiang J, Zhang X
and Yang Y: Compound astragalus and salvia miltiorrhiza extracts
suppress hepatocarcinogenesis by modulating transforming growth
factor-β/Smad signaling. J Gastroenterol Hepatol. 29:1284–1291.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Dzieran J, Fabian J, Feng T, Coulouarn C,
Ilkavets I, Kyselova A, Breuhahn K, Dooley S and Meindl-Beinker NM:
Comparative analysis of TGF-β/Smad signaling dependent cytostasis
in human hepatocellular carcinoma cell lines. PLoS One.
8:e722522013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Park SS, Eom YW, Kim EH, Lee JH, Min DS,
Kim S, Kim SJ and Choi KS: Involvement of c-Src kinase in the
regulation of TGF-beta1-induced apoptosis. Oncogene. 23:6272–6281.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Suzuki HI, Kiyono K and Miyazono K:
Regulation of autophagy by transforming growth factor-β (TGF-β)
signaling. Autophagy. 6:645–647. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Kim BC, Mamura M, Choi KS, Calabretta B
and Kim SJ: Transforming growth factor beta 1 induces apoptosis
through cleavage of BAD in a Smad3-dependent mechanism in FaO
hepatoma cells. Mol Cell Biol. 22:1369–1378. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Ehata S, Johansson E, Katayama R, Koike S,
Watanabe A, Hoshino Y, Katsuno Y, Komuro A, Koinuma D, Kano MR, et
al: Transforming growth factor-β decreases the cancer-initiating
cell population within diffuse-type gastric carcinoma cells.
Oncogene. 30:1693–1705. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Tirino V, Camerlingo R, Bifulco K, Irollo
E, Montella R, Paino F, Sessa G, Carriero MV, Normanno N, Rocco G
and Pirozzi G: TGF-β1 exposure induces epithelial to mesenchymal
transition both in CSCs and non-CSCs of the A549 cell line, leading
to an increase of migration ability in the CD133+ A549 cell
fraction. Cell Death Dis. 4:e6202013. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Yin L, Castagnino P and Assoian RK: ABCG2
expression and side population abundance regulated by a
transforming growth factor beta-directed epithelial-mesenchymal
transition. Cancer Res. 68:800–807. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
You H, Ding W and Rountree CB: Epigenetic
regulation of cancer stem cell marker CD133 by transforming growth
factor-beta. Hepatology. 51:1635–1644. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Martin M, Ancey PB, Cros MP, Durand G, Le
Calvez-Kelm F, Hernandez-Vargas H and Herceg Z: Dynamic imbalance
between cancer cell subpopulations induced by transforming growth
factor beta (TGF-β) is associated with a DNA methylome switch. BMC
Genomics. 15:4352014. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Nishimura T, Azuma T, Yokoyama A, Ochiai
H, Saito H and Hibi T: New mechanism of transforming growth
factor-beta signaling in hepatoma: Dramatic up-regulation of tumor
initiating cells and epidermal growth factor receptor expression.
Hepatol Res. 39:501–509. 2009. View Article : Google Scholar : PubMed/NCBI
|
